Electronic Library for Guideline Developers

[Electronic Library for Guideline Developers]

4. The guideline development group should include individuals from all the relevant professional groups

AZQ
1.4) The answer YES presupposes that a precise description of the names, professional qualification, specialist field, employer and function or kind of participation are available at least for all individuals directly involved in the guideline development (e. g. the members of responsible the steering committee, the work group having performed the search for and the appraisal of the evidence, and, in addition, commentators or reviewers accounted for). 1.5) The answer YES presupposes that professional groups primarily concerned with medical or health care problems, interest groups and patient groups have been involved in the development of guidelines (e. g. general practitioners, specialists, purchasers of health care services, organisations of medical self-government, care organisations, epidemiologists, statistical experts) In case question 1.4 (previous question) was answered NO or UNCLEAR, NOT APPLICABLE should be ticked off.	1.4) Die Antwort JA setzt voraus, dass zumindest für alle direkt an der Leitlinienerstellung beteiligten Personen (z.B. die Mitglieder des verantwortlichen Lenkungsausschusses, die Arbeitsgruppe, welche die Re-cherche und Bewertung der Evidenz durchführte, weiterhin berücksichtigte Kommentatoren oder Gutachter) klare Angaben über Namen, über die beruflichen Qualifikation, über das Fachgebiet, über den Arbeitgeber sowie über die Funktion bzw. die Art ihrer Beteiligung vorliegen. 1.5) Die Antwort "JA" setzt voraus, dass die mit den Gesundheits- bzw. Versorgungsproblemen vorrangig befassten Berufsdisziplinen, Interessen- und Patientengruppen an der Leitlinienerstellung beteiligt waren (z.B. Allgemeinärzte, Fachärzte, Kostenträger, Organisationen der ärztlichen Selbstverwaltung, Pflegeorganisationen, Epidemiologen, Statistiker).Falls Frage 1.4 (vorangehende Frage) mit NEIN oder UNKLAR beantwortet wurde, sollte hier NICHT ANWENDBAR angekreuzt werden.

Current Care
Vetäjä ja vastuutoimittaja neuvottelevat ryhmän kokoonpanon, ja suositeltava koko on 4 - 8 henkeä. Suosituksesta vastaavan yhdistyksen edustaman erikoisalan lisäksi mukaan kutsutaan muiden tarpeellisten erikoisalojen, ammattiryhmien sekä mahdollisesti potilaiden edustajia. Työryhmään kuuluu pääsääntöisesti perusterveydenhuollon asiantuntija (yleislääkäri).
NICE
Convening an effective GDG is one of the most important stages in producing a guideline. The GDG agrees the clinical questions, considers the evidence and develops the recommendations. Membership of the GDG therefore needs to be multidisciplinary, comprising clinicians (both content-area specialists and generalists), patients and/or carers and technical experts. Its exact composition needs to be tailored to the topic covered by the guideline. It should reflect the range of stakeholders or groups whose professional activities or care will be covered by the guidelines and should include at least two lay members with experience or knowledge of patient/carer issues. In addition to the GDG members, there may be individuals with relevant expertise who will be co-opted for discussions. Manufacturers of pharmaceutical products or medical devices are not represented on the GDG but have input into the guideline development process through the GRPs and as stakeholders. Example
SIGN
Information about the composition of the guideline development group is provided in an Annex to each SIGN guideline (or in the front section of guidelines up to no. 50). The guideline development group should be multidisciplinary, including representatives of all the potential users of the guideline. The stated objectives of the guideline often provide an indication of the professions that should be involved in developing the guideline. Development annex (group composition) GDG page from example guideline

If you have any problems in using this resource please contact sign@rcpe.ac.uk
For further information about the AGREE Collaboration contact f.cluzeau@sghms.ac.uk

Last modified 27/4/04